ArticlePeerJ2025
Association of triglyceride-glucose index with postoperative recovery-related factors in type II cesarean scar pregnancy treated by transvaginal surgery.
Article in PeerJ, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Type II cesarean scar pregnancy (CSP) is a rare and serious condition. The triglyceride-glucose index (TyG) may influence postoperative recovery-related factors (PRRF) as a marker of insulin resistance. This study investigates the relationship between TyG and PRRF in patients with type II CSP undergoing transvaginal surgery. Methods: Forty-five patients treated from January 2019 to September 2023 were analyzed. Data on surgical duration, intraoperative blood loss, length of stay, hospitalization costs, and recovery were collected and assessed against TyG levels. Results: A significant correlation was found between TyG and hospitalization costs (β = -677.5, Conclusion: TyG is associated with hospitalization costs and length of stay in type II CSP patients, suggesting its potential to predict healthcare resource utilization. Further research is needed to explore its role in surgical risk assessment.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.